Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Blue

Recent news which mentions Blue

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is A Major Moment For Drug Development
Tickers BLUE COYA GOVX LLY
Tags Coya Therapeutics News Partner Content
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Tickers AMGN BLUE IBB LLY
Tags BLUE XBI AMGN
From Benzinga
Analyst Expectations for bluebird bio's Future
Tickers BLUE
Tags Benzinga BLUE BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Tickers ACMR ADVM ALLK ANET
Tags TCRR SES ESPR
From Benzinga
1 Beaten-Down Stock That Has a Lot to Prove in 2023
Tickers BLUE CRSP VRTX
Tags CRSP Recent Press Releases VRTX
From Motley Fool
What 4 Analyst Ratings Have To Say About bluebird bio
Tickers BLUE
Tags Benzinga BLUE BZI/AAR
From Benzinga
Skechers To Rally 40%? Here Are 10 Other Analyst Forecasts For Monday
Tickers AAPL ALLY BANF BLUE
Tags Price Target News QCOM
From Benzinga
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Tickers BLUE CRSP VRTX
Tags Market News VRTX CRSP
From Motley Fool
Tesla, Amazon, bluebird, Netflix, Discover Financial: Why These 5 Stocks Are Drawing Investors' Attention Today
Tickers AMZN BLUE DFS EVS
Tags EVs Elon Musk DFS
From Benzinga
PNC Financial, bluebird bio And Other Big Stocks Moving Lower On Wednesday
Tickers ARQQ ARVL BHG BLUE
Tags BLUE BHG GRRR
From Benzinga
Why Is Zomedica (ZOM) Stock Up Today?
Tickers BLUE FUV MRNA ZOM
Tags ZOM BLUE NYSEMKT:ZOM,NASDAQ:MRNA,NASDAQ:BLUE,NASDAQ:FUV
From InvestorPlace
Why Bluebird Bio (BLUE) Stock Is Getting Hammered
Tickers BLUE
Tags News why it's moving Small Cap
From Benzinga
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
Tickers BLUE FUV MRNA RDN
Tags Market News RDN BLUE
From InvestorPlace
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Tickers BLUE MRNA
Tags Market News MRNA BLUE
From Motley Fool
Why is Bluebird Bio (BLUE) Stock Down 9% Today?
Tickers BLUE FFIE FUV GS
Tags FFIE Market News RDN
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers ATXI BLUE CLXT CYTH
Tags SGTX VIVE RNXT
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers ARBK ATXI BLUE BTCM
Tags ARBK POET ZOM
From InvestorPlace
2 Stocks That Could Double Your Money in 2023
Tickers AXSM BLUE
Tags Recent Press Releases BLUE Market News
From Motley Fool
Newly Approved Drugs In US Command Over $200,000 On An Average
Tickers BLUE QURE
Tags Small Cap Biotech Briefs
From Benzinga
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
Tickers ARKK BLUE CRSP NTLA
Tags Market News NTLA BLUE
From Motley Fool
After Doubling in the Past 6 Months, Is This Stock a Buy?
Tickers BLUE CRSP VRTX
Tags Market News BLUE CRSP
From Motley Fool
FDA Allows Bluebird Bio To Resume Sickle Cell Disease Studies In Patients Below 18, With Changed Protocol
Tickers BLUE
Tags Market News Trading Ideas Benzinga
From Benzinga
BLUE Stock Alert: What to Know as the FDA Lifts Hold on Bluebird Bio Treatment
Tickers BLUE
Tags BLUE NASDAQ:BLUE Market News
From InvestorPlace
Magenta Therapeutics Shares Surge After Encouraging Data From Blood Cancer Candidate At ASH Meeting
Tickers BLUE MGTA
Tags Movers why it's moving News
From Benzinga
Why Bluebird Bio Stock Crushed the Market Today
Tickers BLUE
Tags Market News Recent Press Releases BLUE
From Motley Fool
2 Risky Stocks That Could Soar in 2023
Tickers BLUE KRYS
Tags Market News KRYS Recent Press Releases
From Motley Fool
Looking Into bluebird bio's Return On Capital Employed
Tickers BLUE
Tags BZI/ROCE Market News Earnings
From Benzinga
Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position
Tickers ARGX BLUE
Tags BLUE Benzinga ARGX
From Benzinga
FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
Tickers BLUE CSLLY QURE
Tags Briefs News CSLLY
From Benzinga
Where Will Editas Medicine Be in 1 Year?
Tickers BLUE CRSP EDIT
Tags BLUE CRSP Recent Press Releases
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.